High Content Screening Market | BioTek Instruments Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories (U.S.), Yokogawa Electric Corporation (Japan), and Merck Millipore (U.S.)
The global high-content screening market is expected to reach USD 909.0 million by 2022 from USD 557.1 million in 2017, at a CAGR of 10.3%. The factors expected to drive the growth of the market are rising need for cost containment in pharmaceutical R&D, growth in funding for cellular research, and technological advancements in HCS solutions during the forecast period. The increasing number of contract research organizations providing HCS outsourcing services and application of HCS in personalized medicine offer significant growth opportunities in the HCS market. The rising adoption of label-free technologies and growing focus on stem cell analysis are the key trends in the HCS market. Know More Details @ https://www.marketsandmarkets.com/Market-Reports/high-content-screening-market-42710391.html In this report, the market is segmented based on product, application, end user, and region. This report also discusses the key market drivers, restraints, opportuni...